# CNI-free "Bottom"-up Immunosuppression in Patients Undergoing Liver Transplantation

> **NCT01023542** · PHASE2,PHASE3 · UNKNOWN · sponsor: **University of Regensburg** · enrollment: 45 (estimated)

## Conditions studied

- Renal Impairment
- Liver Transplantation
- Everolimus

## Interventions

- **DRUG:** delayed, low-dose CNI
- **DRUG:** BU-CNI
- **DRUG:** BU-Everolimus

## Key facts

- **NCT ID:** NCT01023542
- **Lead sponsor:** University of Regensburg
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-06
- **Primary completion:** 2014-07
- **Final completion:** 2014-12
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2011-07-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01023542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01023542, "CNI-free "Bottom"-up Immunosuppression in Patients Undergoing Liver Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01023542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*